Combivair Forte Rotacap is a combination of budesonide, a potent glucocorticoid and formoterol, a selective long-acting beta 2 -agonist.  Budesonide is a potent glucocorticoid that binds with high affinity to the glucocorticoid receptor. It has a high ratio of topical to systemic activity. Formoterol is a very potent long-acting beta 2-agonist with a high intrinsic activity and a rapid onset of action.


Combivair Forte Rotacap: 

Each capsule contains: 

Budesonide 400mcg

Formoterol Fumarate (as Dihydrate) 12mcg 


Combivair Forte Rotacap is indicated in the regular treatment of asthma, where use of a combination (long-acting beta -agonist and inhaled 2 corticosteroid) has been found to be appropriate. Symptomatic treatment of severe chronic obstructive pulmonary disease (COPD) with a history of repeated exacerbations despite regular therapy with long-acting bronchodilators. It is not indicated for the relief of acute bronchospasm.


Capsules are intended for use through Revolizer or Rotaflo only and are not to be swallowed. Dosage is individual and adjusted according to disease severity. When control has been achieved, the dose should be titrated to the lowest effective dose, which could include Combivair Forte Rotacap given once daily.


Combivair Forte Rotacap is contraindicated in patients with a history of hypersensitivity to any of the component of the drug product.


Combivair Forte Rotacaps: Blister pack of 3 X 10’s rotacaps

Patients should consult with their physician before taking any medicine.